BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results